Fibroblast growth factor 1 (CardioVascular BioTherapeutics)

N/A

Report date: 2024/11/20 09:57:25

Base Information

Drug NameFibroblast growth factor 1 (CardioVascular BioTherapeutics)
Drug Alias NameCardio Vascu-Grow成纤维细胞生长因子1 - CardioVascular BioTherapeuticsAcidic FGFCVBT-141CCVBT-141B +[12] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionAngiogenesis inducersFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsWounds and InjuriesConstriction, PathologicDiabetes Mellitus +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCardiovascular Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPhage Pharmaceuticals IncCardiovascular Biotherapeutics Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesConstriction, PathologicDiabetes Mellitus +[10] 

Other Information

ATC CodeN/A
Related LinksN/A